Diabetes mellitus, type 2 Trials in Sugar Land, United States
Conditions / Diabetes mellitus, type 2 / Sugar Land, United States
Diabetes mellitus, type 2 is a medical condition with active clinical research programs worldwide.
69 total trials for this combination
Showing top 10 of 69 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03811561 | A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes | ACTIVE_NOT_RECRUITING | — |
| NCT01243424 | CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT05649137 | A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight | COMPLETED | — |
| NCT01959529 | A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events | COMPLETED | PHASE3 |
| NCT06267391 | Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes | RECRUITING | NA |
| NCT03819153 | A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease | COMPLETED | PHASE3 |
| NCT01336023 | Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT01720446 | Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT02065791 | Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy | COMPLETED | PHASE3 |
| NCT01897532 | Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA) | COMPLETED | PHASE4 |